Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
Langenbeck'S Archives of Surgery|August 4, 2022
Redefining the role of surgery in early small-cell lung cancerFabian Doerr, Sebastian Stange, Maximilian Michel, et al.
Journal of Cardiothoracic Surgery|September 20, 2011
Logistic Organ Dysfunction Score (LODS): a reliable postoperative risk management score also in cardiac surgical patients?Matthias B Heldwein, Akmal M A Badreldin, Fabian Doerr, et al.
Lung|June 29, 2022
Stage I and II Small-Cell Lung Cancer-New Challenge for SurgeryFabian Doerr, Sebastian Stange, Maximilian Michel, et al.
Respiratory Medicine Case Reports|August 29, 2022
Neoadjuvant chemoimmunotherapy as a potential therapeutic option in NSCLC UICC stage IIIA with multilevel N2 diseaseHruy Menghesha, Fabian Doerr, Georg Schlachtenberger, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|June 13, 2013
Rapid clinical evaluation: an early warning cardiac surgical scoring system for hand-held digital devicesAkmal M A Badreldin, Fabian Doerr, Edward M Bender, et al.
Journal of Cardiothoracic Surgery|March 3, 2011
A comparative study of four intensive care outcome prediction models in cardiac surgery patientsFabian Doerr, Akmal Ma Badreldin, Matthias B Heldwein, et al.
Medical Science Monitor Basic Research|August 18, 2015
Combination of European System for Cardiac Operative Risk Evaluation (EuroSCORE) and Cardiac Surgery Score (CASUS) to Improve Outcome Prediction in Cardiac SurgeryFabian Doerr, Matthias B Heldwein, Ole Bayer, et al.
Medical Science Monitor Basic Research|July 4, 2015
Inclusion of 'ICU-Day' in a Logistic Scoring System Improves Mortality Prediction in Cardiac SurgeryFabian Doerr, Matthias B Heldwein, Ole Bayer, et al.
Expert Review of Anticancer Therapy|January 28, 2023
Prognostic impact of lymph node spreading pattern in N2 NSCLC patientsGeorg Schlachtenberger, Fabian Doerr, Hruy Menghesha, et al.
Surgical Oncology|September 12, 2022
Sublobar resection without staging and lymphadenectomy for ≤2 cm Non-Small Cell Lung Cancer is no adequate therapyGeorg Schlachtenberger, Fabian Doerr, Hruy Menghesha, et al.
Pageof 6